In addition, several lines of evidence indicate that NF-κB plays a significant role in pancreatic cancer resistance to apoptosis-based chemotherapies, leading to NF-kB being suggested as a potential molecular target for pancreatic cancer therapy [8]. The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.